OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 65 filers reported holding OVID THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $548,576 | +17.1% | 142,858 | +0.0% | 0.00% | – |
Q2 2023 | $468,509 | +27.1% | 142,838 | 0.0% | 0.00% | – |
Q1 2023 | $368,522 | +549932.8% | 142,838 | +300.1% | 0.00% | – |
Q4 2022 | $67 | -99.9% | 35,704 | -14.4% | 0.00% | – |
Q3 2022 | $77,000 | +26.2% | 41,720 | +113.2% | 0.00% | – |
Q1 2022 | $61,000 | -3.2% | 19,564 | 0.0% | 0.00% | – |
Q4 2021 | $63,000 | -79.2% | 19,564 | -63.0% | 0.00% | – |
Q3 2020 | $303,000 | -22.1% | 52,819 | 0.0% | 0.00% | – |
Q2 2020 | $389,000 | +111.4% | 52,819 | -14.5% | 0.00% | – |
Q1 2020 | $184,000 | -51.1% | 61,794 | -31.9% | 0.00% | – |
Q4 2019 | $376,000 | +27.9% | 90,701 | 0.0% | 0.00% | – |
Q3 2019 | $294,000 | +75.0% | 90,701 | 0.0% | 0.00% | – |
Q2 2019 | $168,000 | +4.3% | 90,701 | 0.0% | 0.00% | – |
Q1 2019 | $161,000 | -23.7% | 90,701 | +3.9% | 0.00% | – |
Q4 2018 | $211,000 | -52.5% | 87,257 | +11.5% | 0.00% | – |
Q3 2018 | $444,000 | – | 78,262 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TLS Advisors LLC | 1,319,679 | $5,068 | 20.50% |
Madison Avenue Partners, LP | 3,648,509 | $14,010,275 | 1.99% |
CHI Advisors LLC | 864,822 | $3,320,916 | 1.32% |
EcoR1 Capital, LLC | 6,117,400 | $23,490,816 | 0.79% |
Rubric Capital Management LP | 5,445,910 | $20,912,294 | 0.78% |
BVF INC/IL | 6,851,051 | $26,308,036 | 0.71% |
Artal Group S.A. | 2,500,000 | $9,600 | 0.41% |
DCF Advisers, LLC | 30,430 | $116,851 | 0.06% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 458,700 | $1,761,408 | 0.04% |
ACADIAN ASSET MANAGEMENT LLC | 1,701,228 | $6,531 | 0.03% |